nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP3A4—breast cancer	0.21	1	CbGaD
Sulfadiazine—CYP2C9—Anastrozole—breast cancer	0.0433	0.0773	CbGbCtD
Sulfadiazine—CYP2C8—Lapatinib—breast cancer	0.0415	0.0739	CbGbCtD
Sulfadiazine—CYP3A4—Exemestane—breast cancer	0.0332	0.0593	CbGbCtD
Sulfadiazine—CYP2C9—Idarubicin—breast cancer	0.0328	0.0586	CbGbCtD
Sulfadiazine—CYP2C8—Raloxifene—breast cancer	0.0314	0.056	CbGbCtD
Sulfadiazine—CYP3A4—Letrozole—breast cancer	0.0283	0.0504	CbGbCtD
Sulfadiazine—CYP2E1—Tamoxifen—breast cancer	0.0278	0.0496	CbGbCtD
Sulfadiazine—CYP2E1—Mitoxantrone—breast cancer	0.0271	0.0483	CbGbCtD
Sulfadiazine—CYP3A4—Anastrozole—breast cancer	0.0252	0.0449	CbGbCtD
Sulfadiazine—CYP3A4—Toremifene—breast cancer	0.023	0.0411	CbGbCtD
Sulfadiazine—CYP3A4—Fulvestrant—breast cancer	0.0214	0.0382	CbGbCtD
Sulfadiazine—CYP2C8—Tamoxifen—breast cancer	0.0208	0.037	CbGbCtD
Sulfadiazine—CYP3A4—Thiotepa—breast cancer	0.0191	0.0341	CbGbCtD
Sulfadiazine—CYP2C9—Capecitabine—breast cancer	0.018	0.0321	CbGbCtD
Sulfadiazine—CYP3A4—Ixabepilone—breast cancer	0.0175	0.0312	CbGbCtD
Sulfadiazine—CYP3A4—Lapatinib—breast cancer	0.0168	0.03	CbGbCtD
Sulfadiazine—CYP2C8—Paclitaxel—breast cancer	0.0162	0.0288	CbGbCtD
Sulfadiazine—CYP2C8—Fluorouracil—breast cancer	0.0153	0.0273	CbGbCtD
Sulfadiazine—CYP2C9—Tamoxifen—breast cancer	0.0145	0.0258	CbGbCtD
Sulfadiazine—CYP3A4—Raloxifene—breast cancer	0.0127	0.0227	CbGbCtD
Sulfadiazine—CYP2C9—Paclitaxel—breast cancer	0.0113	0.0201	CbGbCtD
Sulfadiazine—CYP2C9—Fluorouracil—breast cancer	0.0107	0.019	CbGbCtD
Sulfadiazine—CYP3A4—Vinorelbine—breast cancer	0.00933	0.0166	CbGbCtD
Sulfadiazine—CYP3A4—Tamoxifen—breast cancer	0.00842	0.015	CbGbCtD
Sulfadiazine—CYP3A4—Mitoxantrone—breast cancer	0.00821	0.0146	CbGbCtD
Sulfadiazine—CYP3A4—Paclitaxel—breast cancer	0.00655	0.0117	CbGbCtD
Sulfadiazine—CYP3A4—Irinotecan—breast cancer	0.00646	0.0115	CbGbCtD
Sulfadiazine—CYP3A4—Vinblastine—breast cancer	0.00575	0.0103	CbGbCtD
Sulfadiazine—CYP3A4—Docetaxel—breast cancer	0.00474	0.00845	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—breast cancer	0.00353	0.0063	CbGbCtD
Sulfadiazine—Sulfasalazine—SLCO1B1—breast cancer	0.000533	0.125	CrCbGaD
Sulfadiazine—Sulfamethoxazole—NAT2—breast cancer	0.00053	0.124	CrCbGaD
Sulfadiazine—Sulfathiazole—CYP19A1—breast cancer	0.000481	0.113	CrCbGaD
Sulfadiazine—Dapsone—NAT2—breast cancer	0.000415	0.0972	CrCbGaD
Sulfadiazine—Sulfanilamide—CA9—breast cancer	0.000292	0.0684	CrCbGaD
Sulfadiazine—Sulfasalazine—ABCG2—breast cancer	0.000232	0.0543	CrCbGaD
Sulfadiazine—Sulfasalazine—PTGS1—breast cancer	0.000199	0.0465	CrCbGaD
Sulfadiazine—Sulfamethazine—ALB—breast cancer	0.000197	0.0461	CrCbGaD
Sulfadiazine—Sulfamerazine—ALB—breast cancer	0.000192	0.0451	CrCbGaD
Sulfadiazine—Sulfamethoxazole—PTGS1—breast cancer	0.000164	0.0385	CrCbGaD
Sulfadiazine—Sulfamethizole—ALB—breast cancer	0.000149	0.035	CrCbGaD
Sulfadiazine—Sulfaphenazole—CYP2D6—breast cancer	0.000132	0.031	CrCbGaD
Sulfadiazine—Dapsone—PTGS1—breast cancer	0.000129	0.0301	CrCbGaD
Sulfadiazine—Hypoglycaemia—Doxorubicin—breast cancer	0.000124	0.000736	CcSEcCtD
Sulfadiazine—Vertigo—Paclitaxel—breast cancer	0.000124	0.000735	CcSEcCtD
Sulfadiazine—Leukopenia—Paclitaxel—breast cancer	0.000124	0.000732	CcSEcCtD
Sulfadiazine—Rash—Tamoxifen—breast cancer	0.000124	0.000732	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vinorelbine—breast cancer	0.000124	0.000731	CcSEcCtD
Sulfadiazine—Dermatitis—Tamoxifen—breast cancer	0.000123	0.000731	CcSEcCtD
Sulfadiazine—Ataxia—Epirubicin—breast cancer	0.000123	0.00073	CcSEcCtD
Sulfadiazine—Erythema multiforme—Capecitabine—breast cancer	0.000123	0.000729	CcSEcCtD
Sulfadiazine—Headache—Tamoxifen—breast cancer	0.000123	0.000727	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000123	0.000727	CcSEcCtD
Sulfadiazine—Vomiting—Melphalan—breast cancer	0.000122	0.000723	CcSEcCtD
Sulfadiazine—Insomnia—Gemcitabine—breast cancer	0.000122	0.000721	CcSEcCtD
Sulfadiazine—Tinnitus—Capecitabine—breast cancer	0.000121	0.000719	CcSEcCtD
Sulfadiazine—Rash—Melphalan—breast cancer	0.000121	0.000717	CcSEcCtD
Sulfadiazine—Dermatitis—Melphalan—breast cancer	0.000121	0.000716	CcSEcCtD
Sulfadiazine—Chills—Docetaxel—breast cancer	0.000121	0.000715	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000121	0.000715	CcSEcCtD
Sulfadiazine—Decreased appetite—Irinotecan—breast cancer	0.00012	0.000712	CcSEcCtD
Sulfadiazine—Decreased appetite—Mitoxantrone—breast cancer	0.00012	0.000712	CcSEcCtD
Sulfadiazine—Nausea—Vinblastine—breast cancer	0.00012	0.00071	CcSEcCtD
Sulfadiazine—Insomnia—Fluorouracil—breast cancer	0.00012	0.000709	CcSEcCtD
Sulfadiazine—Convulsion—Paclitaxel—breast cancer	0.00012	0.000709	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Irinotecan—breast cancer	0.000119	0.000707	CcSEcCtD
Sulfadiazine—Vomiting—Goserelin—breast cancer	0.000119	0.000705	CcSEcCtD
Sulfadiazine—Pancreatitis—Methotrexate—breast cancer	0.000119	0.000703	CcSEcCtD
Sulfadiazine—Pruritus—Vinorelbine—breast cancer	0.000119	0.000702	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.000118	0.000699	CcSEcCtD
Sulfadiazine—Rash—Goserelin—breast cancer	0.000118	0.000699	CcSEcCtD
Sulfadiazine—Hypersensitivity—Thiotepa—breast cancer	0.000118	0.000699	CcSEcCtD
Sulfadiazine—Dermatitis—Goserelin—breast cancer	0.000118	0.000698	CcSEcCtD
Sulfadiazine—Arthralgia—Paclitaxel—breast cancer	0.000118	0.000697	CcSEcCtD
Sulfadiazine—Headache—Goserelin—breast cancer	0.000117	0.000694	CcSEcCtD
Sulfadiazine—Decreased appetite—Gemcitabine—breast cancer	0.000117	0.000693	CcSEcCtD
Sulfadiazine—Chills—Capecitabine—breast cancer	0.000117	0.000692	CcSEcCtD
Sulfadiazine—Nausea—Tamoxifen—breast cancer	0.000116	0.000689	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000116	0.000689	CcSEcCtD
Sulfadiazine—Decreased appetite—Fluorouracil—breast cancer	0.000115	0.000682	CcSEcCtD
Sulfadiazine—Diarrhoea—Vinorelbine—breast cancer	0.000115	0.000679	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000114	0.000677	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—breast cancer	0.000114	0.000676	CcSEcCtD
Sulfadiazine—Nausea—Melphalan—breast cancer	0.000114	0.000675	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS2—breast cancer	0.000113	0.0266	CrCbGaD
Sulfadiazine—Pruritus—Thiotepa—breast cancer	0.000113	0.000671	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Irinotecan—breast cancer	0.000113	0.00067	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000113	0.00067	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Paclitaxel—breast cancer	0.000113	0.000668	CcSEcCtD
Sulfadiazine—Nausea—Goserelin—breast cancer	0.000111	0.000658	CcSEcCtD
Sulfadiazine—Pancreatitis—Epirubicin—breast cancer	0.000111	0.000658	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Paclitaxel—breast cancer	0.00011	0.000654	CcSEcCtD
Sulfadiazine—Urticaria—Mitoxantrone—breast cancer	0.00011	0.00065	CcSEcCtD
Sulfadiazine—Diarrhoea—Thiotepa—breast cancer	0.00011	0.000649	CcSEcCtD
Sulfadiazine—Abdominal pain—Mitoxantrone—breast cancer	0.000109	0.000647	CcSEcCtD
Sulfadiazine—Abdominal pain—Irinotecan—breast cancer	0.000109	0.000647	CcSEcCtD
Sulfadiazine—Body temperature increased—Mitoxantrone—breast cancer	0.000109	0.000647	CcSEcCtD
Sulfadiazine—Body temperature increased—Irinotecan—breast cancer	0.000109	0.000647	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000109	0.000647	CcSEcCtD
Sulfadiazine—Depression—Methotrexate—breast cancer	0.000108	0.000638	CcSEcCtD
Sulfadiazine—Anorexia—Paclitaxel—breast cancer	0.000107	0.000637	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000107	0.000634	CcSEcCtD
Sulfadiazine—Vomiting—Vinorelbine—breast cancer	0.000107	0.000631	CcSEcCtD
Sulfadiazine—Body temperature increased—Gemcitabine—breast cancer	0.000106	0.000631	CcSEcCtD
Sulfadiazine—Rash—Vinorelbine—breast cancer	0.000106	0.000626	CcSEcCtD
Sulfadiazine—Dermatitis—Vinorelbine—breast cancer	0.000106	0.000625	CcSEcCtD
Sulfadiazine—Stomatitis—Methotrexate—breast cancer	0.000105	0.000624	CcSEcCtD
Sulfadiazine—Urticaria—Fluorouracil—breast cancer	0.000105	0.000623	CcSEcCtD
Sulfadiazine—Headache—Vinorelbine—breast cancer	0.000105	0.000622	CcSEcCtD
Sulfadiazine—Leukopenia—Docetaxel—breast cancer	0.000105	0.000621	CcSEcCtD
Sulfadiazine—Body temperature increased—Fluorouracil—breast cancer	0.000105	0.00062	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—breast cancer	0.000103	0.000609	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000103	0.000608	CcSEcCtD
Sulfadiazine—Insomnia—Paclitaxel—breast cancer	0.000102	0.000604	CcSEcCtD
Sulfadiazine—Vertigo—Capecitabine—breast cancer	0.000102	0.000603	CcSEcCtD
Sulfadiazine—Hypersensitivity—Irinotecan—breast cancer	0.000102	0.000603	CcSEcCtD
Sulfadiazine—Hypersensitivity—Mitoxantrone—breast cancer	0.000102	0.000603	CcSEcCtD
Sulfadiazine—Vomiting—Thiotepa—breast cancer	0.000102	0.000603	CcSEcCtD
Sulfadiazine—Leukopenia—Capecitabine—breast cancer	0.000101	0.000601	CcSEcCtD
Sulfadiazine—Convulsion—Docetaxel—breast cancer	0.000101	0.000601	CcSEcCtD
Sulfadiazine—Rash—Thiotepa—breast cancer	0.000101	0.000598	CcSEcCtD
Sulfadiazine—Dermatitis—Thiotepa—breast cancer	0.000101	0.000597	CcSEcCtD
Sulfadiazine—Agranulocytosis—Methotrexate—breast cancer	0.000101	0.000597	CcSEcCtD
Sulfadiazine—Headache—Thiotepa—breast cancer	0.0001	0.000594	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.0001	0.000593	CcSEcCtD
Sulfadiazine—Arthralgia—Docetaxel—breast cancer	9.97e-05	0.00059	CcSEcCtD
Sulfadiazine—Nausea—Vinorelbine—breast cancer	9.96e-05	0.00059	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Epirubicin—breast cancer	9.91e-05	0.000587	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—breast cancer	9.85e-05	0.000584	CcSEcCtD
Sulfadiazine—Sulfanilamide—CYP2D6—breast cancer	9.82e-05	0.023	CrCbGaD
Sulfadiazine—Decreased appetite—Paclitaxel—breast cancer	9.8e-05	0.000581	CcSEcCtD
Sulfadiazine—Hypersensitivity—Fluorouracil—breast cancer	9.76e-05	0.000578	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Paclitaxel—breast cancer	9.73e-05	0.000577	CcSEcCtD
Sulfadiazine—Hepatitis—Methotrexate—breast cancer	9.7e-05	0.000574	CcSEcCtD
Sulfadiazine—Arthralgia—Capecitabine—breast cancer	9.65e-05	0.000572	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—CYP3A4—breast cancer	9.6e-05	0.0225	CrCbGaD
Sulfadiazine—Anaphylactic shock—Docetaxel—breast cancer	9.56e-05	0.000566	CcSEcCtD
Sulfadiazine—Pruritus—Gemcitabine—breast cancer	9.53e-05	0.000564	CcSEcCtD
Sulfadiazine—Nausea—Thiotepa—breast cancer	9.51e-05	0.000563	CcSEcCtD
Sulfadiazine—Diarrhoea—Irinotecan—breast cancer	9.46e-05	0.00056	CcSEcCtD
Sulfadiazine—Diarrhoea—Mitoxantrone—breast cancer	9.46e-05	0.00056	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—breast cancer	9.43e-05	0.000559	CcSEcCtD
Sulfadiazine—Pruritus—Fluorouracil—breast cancer	9.37e-05	0.000555	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Docetaxel—breast cancer	9.36e-05	0.000554	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	9.27e-05	0.000549	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Paclitaxel—breast cancer	9.22e-05	0.000546	CcSEcCtD
Sulfadiazine—Diarrhoea—Gemcitabine—breast cancer	9.21e-05	0.000546	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—breast cancer	9.17e-05	0.000543	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—breast cancer	9.17e-05	0.000543	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—breast cancer	9.12e-05	0.00054	CcSEcCtD
Sulfadiazine—Anorexia—Docetaxel—breast cancer	9.11e-05	0.00054	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—breast cancer	9.07e-05	0.000537	CcSEcCtD
Sulfadiazine—Diarrhoea—Fluorouracil—breast cancer	9.06e-05	0.000537	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Capecitabine—breast cancer	9.06e-05	0.000537	CcSEcCtD
Sulfadiazine—Tinnitus—Methotrexate—breast cancer	9.04e-05	0.000535	CcSEcCtD
Sulfadiazine—Urticaria—Paclitaxel—breast cancer	8.96e-05	0.000531	CcSEcCtD
Sulfadiazine—Body temperature increased—Paclitaxel—breast cancer	8.91e-05	0.000528	CcSEcCtD
Sulfadiazine—Abdominal pain—Paclitaxel—breast cancer	8.91e-05	0.000528	CcSEcCtD
Sulfadiazine—Anorexia—Capecitabine—breast cancer	8.82e-05	0.000522	CcSEcCtD
Sulfadiazine—Vomiting—Irinotecan—breast cancer	8.79e-05	0.000521	CcSEcCtD
Sulfadiazine—Vomiting—Mitoxantrone—breast cancer	8.79e-05	0.000521	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—breast cancer	8.73e-05	0.000517	CcSEcCtD
Sulfadiazine—Rash—Mitoxantrone—breast cancer	8.72e-05	0.000516	CcSEcCtD
Sulfadiazine—Rash—Irinotecan—breast cancer	8.72e-05	0.000516	CcSEcCtD
Sulfadiazine—Dermatitis—Mitoxantrone—breast cancer	8.71e-05	0.000516	CcSEcCtD
Sulfadiazine—Dermatitis—Irinotecan—breast cancer	8.71e-05	0.000516	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Docetaxel—breast cancer	8.71e-05	0.000516	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—breast cancer	8.7e-05	0.000515	CcSEcCtD
Sulfadiazine—Headache—Irinotecan—breast cancer	8.66e-05	0.000513	CcSEcCtD
Sulfadiazine—Headache—Mitoxantrone—breast cancer	8.66e-05	0.000513	CcSEcCtD
Sulfadiazine—Insomnia—Docetaxel—breast cancer	8.64e-05	0.000512	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—breast cancer	8.58e-05	0.000508	CcSEcCtD
Sulfadiazine—Vomiting—Gemcitabine—breast cancer	8.56e-05	0.000507	CcSEcCtD
Sulfadiazine—Rash—Gemcitabine—breast cancer	8.49e-05	0.000503	CcSEcCtD
Sulfadiazine—Dermatitis—Gemcitabine—breast cancer	8.48e-05	0.000502	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—breast cancer	8.46e-05	0.000501	CcSEcCtD
Sulfadiazine—Headache—Gemcitabine—breast cancer	8.44e-05	0.0005	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Capecitabine—breast cancer	8.43e-05	0.000499	CcSEcCtD
Sulfadiazine—Sulfanilamide—CYP3A4—breast cancer	8.42e-05	0.0197	CrCbGaD
Sulfadiazine—Vomiting—Fluorouracil—breast cancer	8.42e-05	0.000499	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—breast cancer	8.4e-05	0.000497	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—ALB—breast cancer	8.38e-05	0.0196	CrCbGaD
Sulfadiazine—Insomnia—Capecitabine—breast cancer	8.37e-05	0.000496	CcSEcCtD
Sulfadiazine—Rash—Fluorouracil—breast cancer	8.35e-05	0.000494	CcSEcCtD
Sulfadiazine—Dermatitis—Fluorouracil—breast cancer	8.34e-05	0.000494	CcSEcCtD
Sulfadiazine—Decreased appetite—Docetaxel—breast cancer	8.31e-05	0.000492	CcSEcCtD
Sulfadiazine—Hypersensitivity—Paclitaxel—breast cancer	8.31e-05	0.000492	CcSEcCtD
Sulfadiazine—Headache—Fluorouracil—breast cancer	8.3e-05	0.000491	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Docetaxel—breast cancer	8.25e-05	0.000489	CcSEcCtD
Sulfadiazine—Nausea—Irinotecan—breast cancer	8.21e-05	0.000486	CcSEcCtD
Sulfadiazine—Nausea—Mitoxantrone—breast cancer	8.21e-05	0.000486	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—breast cancer	8.14e-05	0.000482	CcSEcCtD
Sulfadiazine—Decreased appetite—Capecitabine—breast cancer	8.04e-05	0.000476	CcSEcCtD
Sulfadiazine—Nausea—Gemcitabine—breast cancer	8e-05	0.000474	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Capecitabine—breast cancer	7.99e-05	0.000473	CcSEcCtD
Sulfadiazine—Pruritus—Paclitaxel—breast cancer	7.98e-05	0.000472	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—breast cancer	7.94e-05	0.00047	CcSEcCtD
Sulfadiazine—Nausea—Fluorouracil—breast cancer	7.87e-05	0.000466	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—breast cancer	7.83e-05	0.000464	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Docetaxel—breast cancer	7.82e-05	0.000463	CcSEcCtD
Sulfadiazine—Diarrhoea—Paclitaxel—breast cancer	7.71e-05	0.000457	CcSEcCtD
Sulfadiazine—Vertigo—Methotrexate—breast cancer	7.58e-05	0.000449	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Capecitabine—breast cancer	7.57e-05	0.000448	CcSEcCtD
Sulfadiazine—Body temperature increased—Docetaxel—breast cancer	7.56e-05	0.000447	CcSEcCtD
Sulfadiazine—Abdominal pain—Docetaxel—breast cancer	7.56e-05	0.000447	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—breast cancer	7.56e-05	0.000447	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—breast cancer	7.53e-05	0.000446	CcSEcCtD
Sulfadiazine—Dapsone—CYP3A4—breast cancer	7.51e-05	0.0176	CrCbGaD
Sulfadiazine—Dapsone—PTGS2—breast cancer	7.36e-05	0.0172	CrCbGaD
Sulfadiazine—Urticaria—Capecitabine—breast cancer	7.35e-05	0.000435	CcSEcCtD
Sulfadiazine—Abdominal pain—Capecitabine—breast cancer	7.31e-05	0.000433	CcSEcCtD
Sulfadiazine—Body temperature increased—Capecitabine—breast cancer	7.31e-05	0.000433	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—breast cancer	7.31e-05	0.000433	CcSEcCtD
Sulfadiazine—Arthralgia—Methotrexate—breast cancer	7.19e-05	0.000426	CcSEcCtD
Sulfadiazine—Vomiting—Paclitaxel—breast cancer	7.17e-05	0.000425	CcSEcCtD
Sulfadiazine—Rash—Paclitaxel—breast cancer	7.11e-05	0.000421	CcSEcCtD
Sulfadiazine—Dermatitis—Paclitaxel—breast cancer	7.1e-05	0.000421	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—breast cancer	7.1e-05	0.00042	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—breast cancer	7.07e-05	0.000419	CcSEcCtD
Sulfadiazine—Headache—Paclitaxel—breast cancer	7.06e-05	0.000418	CcSEcCtD
Sulfadiazine—Hypersensitivity—Docetaxel—breast cancer	7.04e-05	0.000417	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methotrexate—breast cancer	6.89e-05	0.000408	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—breast cancer	6.84e-05	0.000405	CcSEcCtD
Sulfadiazine—Hypersensitivity—Capecitabine—breast cancer	6.82e-05	0.000404	CcSEcCtD
Sulfadiazine—Pruritus—Docetaxel—breast cancer	6.76e-05	0.0004	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Methotrexate—breast cancer	6.74e-05	0.000399	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—breast cancer	6.72e-05	0.000398	CcSEcCtD
Sulfadiazine—Nausea—Paclitaxel—breast cancer	6.7e-05	0.000397	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—breast cancer	6.57e-05	0.000389	CcSEcCtD
Sulfadiazine—Anorexia—Methotrexate—breast cancer	6.57e-05	0.000389	CcSEcCtD
Sulfadiazine—Pruritus—Capecitabine—breast cancer	6.55e-05	0.000388	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—breast cancer	6.54e-05	0.000387	CcSEcCtD
Sulfadiazine—Diarrhoea—Docetaxel—breast cancer	6.54e-05	0.000387	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—breast cancer	6.45e-05	0.000382	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—breast cancer	6.33e-05	0.000375	CcSEcCtD
Sulfadiazine—Diarrhoea—Capecitabine—breast cancer	6.33e-05	0.000375	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—breast cancer	6.31e-05	0.000374	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—breast cancer	6.28e-05	0.000372	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—breast cancer	6.23e-05	0.000369	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—breast cancer	6.22e-05	0.000369	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—breast cancer	6.14e-05	0.000364	CcSEcCtD
Sulfadiazine—Vomiting—Docetaxel—breast cancer	6.08e-05	0.00036	CcSEcCtD
Sulfadiazine—Rash—Docetaxel—breast cancer	6.03e-05	0.000357	CcSEcCtD
Sulfadiazine—Dermatitis—Docetaxel—breast cancer	6.02e-05	0.000357	CcSEcCtD
Sulfadiazine—Decreased appetite—Methotrexate—breast cancer	5.99e-05	0.000355	CcSEcCtD
Sulfadiazine—Headache—Docetaxel—breast cancer	5.99e-05	0.000355	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—breast cancer	5.96e-05	0.000353	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—breast cancer	5.95e-05	0.000352	CcSEcCtD
Sulfadiazine—Vomiting—Capecitabine—breast cancer	5.88e-05	0.000348	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—breast cancer	5.87e-05	0.000348	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—breast cancer	5.84e-05	0.000346	CcSEcCtD
Sulfadiazine—Rash—Capecitabine—breast cancer	5.83e-05	0.000346	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—breast cancer	5.83e-05	0.000345	CcSEcCtD
Sulfadiazine—Dermatitis—Capecitabine—breast cancer	5.83e-05	0.000345	CcSEcCtD
Sulfadiazine—Headache—Capecitabine—breast cancer	5.8e-05	0.000343	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—breast cancer	5.69e-05	0.000337	CcSEcCtD
Sulfadiazine—Nausea—Docetaxel—breast cancer	5.68e-05	0.000336	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methotrexate—breast cancer	5.63e-05	0.000334	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—breast cancer	5.6e-05	0.000332	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—breast cancer	5.57e-05	0.00033	CcSEcCtD
Sulfadiazine—Nausea—Capecitabine—breast cancer	5.5e-05	0.000326	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—breast cancer	5.47e-05	0.000324	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—breast cancer	5.45e-05	0.000323	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—breast cancer	5.45e-05	0.000323	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.43e-05	0.000322	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—breast cancer	5.39e-05	0.00032	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—breast cancer	5.27e-05	0.000312	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—breast cancer	5.19e-05	0.000307	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—breast cancer	5.15e-05	0.000305	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—breast cancer	5.12e-05	0.000303	CcSEcCtD
Sulfadiazine—Body temperature increased—Epirubicin—breast cancer	5.1e-05	0.000302	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—breast cancer	5.1e-05	0.000302	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methotrexate—breast cancer	5.08e-05	0.000301	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—breast cancer	4.88e-05	0.000289	CcSEcCtD
Sulfadiazine—Pruritus—Methotrexate—breast cancer	4.87e-05	0.000289	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—breast cancer	4.75e-05	0.000281	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—breast cancer	4.74e-05	0.000281	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—breast cancer	4.72e-05	0.000279	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—breast cancer	4.72e-05	0.000279	CcSEcCtD
Sulfadiazine—Diarrhoea—Methotrexate—breast cancer	4.71e-05	0.000279	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—breast cancer	4.56e-05	0.00027	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—breast cancer	4.41e-05	0.000261	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—breast cancer	4.39e-05	0.00026	CcSEcCtD
Sulfadiazine—Vomiting—Methotrexate—breast cancer	4.38e-05	0.000259	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—breast cancer	4.34e-05	0.000257	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—breast cancer	4.34e-05	0.000257	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—breast cancer	4.32e-05	0.000256	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—breast cancer	4.22e-05	0.00025	CcSEcCtD
Sulfadiazine—Vomiting—Epirubicin—breast cancer	4.1e-05	0.000243	CcSEcCtD
Sulfadiazine—Nausea—Methotrexate—breast cancer	4.09e-05	0.000242	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—breast cancer	4.08e-05	0.000242	CcSEcCtD
Sulfadiazine—Rash—Epirubicin—breast cancer	4.06e-05	0.000241	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—breast cancer	4.06e-05	0.000241	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—breast cancer	4.04e-05	0.000239	CcSEcCtD
Sulfadiazine—Nausea—Epirubicin—breast cancer	3.83e-05	0.000227	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—breast cancer	3.79e-05	0.000225	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—breast cancer	3.76e-05	0.000223	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—breast cancer	3.76e-05	0.000223	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—breast cancer	3.74e-05	0.000221	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—breast cancer	3.54e-05	0.00021	CcSEcCtD
Sulfadiazine—CYP2E1—Metabolism—ACHE—breast cancer	1.16e-05	0.000206	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CDA—breast cancer	1.16e-05	0.000205	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SHMT1—breast cancer	1.16e-05	0.000205	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MED12—breast cancer	1.14e-05	0.000201	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—DPYD—breast cancer	1.14e-05	0.000201	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA4—breast cancer	1.14e-05	0.000201	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CA9—breast cancer	1.14e-05	0.000201	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.12e-05	0.000198	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDOA—breast cancer	1.12e-05	0.000198	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC2A5—breast cancer	1.12e-05	0.000198	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.12e-05	0.000198	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.11e-05	0.000196	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA2—breast cancer	1.11e-05	0.000196	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GPX2—breast cancer	1.11e-05	0.000196	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP17A1—breast cancer	1.1e-05	0.000195	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GPX4—breast cancer	1.09e-05	0.000193	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SULT1A1—breast cancer	1.09e-05	0.000193	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ENO1—breast cancer	1.09e-05	0.000193	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS1—breast cancer	1.09e-05	0.000193	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOA3—breast cancer	1.09e-05	0.000192	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APRT—breast cancer	1.08e-05	0.000191	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC2A2—breast cancer	1.08e-05	0.000191	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2D6—breast cancer	1.07e-05	0.000189	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.07e-05	0.000189	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA1—breast cancer	1.07e-05	0.000189	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—IDH1—breast cancer	1.07e-05	0.000189	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTR—breast cancer	1.06e-05	0.000187	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCG2—breast cancer	1.06e-05	0.000187	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CPT1A—breast cancer	1.06e-05	0.000187	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NAT2—breast cancer	1.06e-05	0.000187	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NCOA2—breast cancer	1.05e-05	0.000186	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HPGDS—breast cancer	1.04e-05	0.000183	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HBA1—breast cancer	1.03e-05	0.000182	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—FASN—breast cancer	1.02e-05	0.00018	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ESRRA—breast cancer	1.02e-05	0.00018	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.02e-05	0.00018	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—BCHE—breast cancer	1.01e-05	0.000179	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTT1—breast cancer	1.01e-05	0.000178	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ACHE—breast cancer	1.01e-05	0.000178	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC5A5—breast cancer	1e-05	0.000177	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NQO1—breast cancer	9.68e-06	0.000171	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC2A1—breast cancer	9.68e-06	0.000171	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HADHB—breast cancer	9.64e-06	0.00017	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPI—breast cancer	9.64e-06	0.00017	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.55e-06	0.000169	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP17A1—breast cancer	9.53e-06	0.000168	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP3A4—breast cancer	9.44e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ENO1—breast cancer	9.43e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS1—breast cancer	9.43e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	9.4e-06	0.000166	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1B1—breast cancer	9.28e-06	0.000164	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	9.28e-06	0.000164	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MED12—breast cancer	9.27e-06	0.000164	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—DPYD—breast cancer	9.27e-06	0.000164	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2D6—breast cancer	9.25e-06	0.000163	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDH7A1—breast cancer	9.2e-06	0.000162	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDH1A1—breast cancer	9.2e-06	0.000162	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDOA—breast cancer	9.12e-06	0.000161	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HSP90AA1—breast cancer	9.1e-06	0.000161	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOA2—breast cancer	9.08e-06	0.00016	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOA3—breast cancer	8.86e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NCOA1—breast cancer	8.85e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—UMPS—breast cancer	8.82e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PHGDH—breast cancer	8.82e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADSL—breast cancer	8.82e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—FHL2—breast cancer	8.82e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NME1—breast cancer	8.82e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—FASN—breast cancer	8.81e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC2A2—breast cancer	8.79e-06	0.000155	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—BCHE—breast cancer	8.77e-06	0.000155	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—STK11—breast cancer	8.72e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP19A1—breast cancer	8.72e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.7e-06	0.000154	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC5A5—breast cancer	8.66e-06	0.000153	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HPSE—breast cancer	8.65e-06	0.000153	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—BRIP1—breast cancer	8.65e-06	0.000153	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LDHB—breast cancer	8.65e-06	0.000153	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCG2—breast cancer	8.61e-06	0.000152	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CPT1A—breast cancer	8.61e-06	0.000152	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTR—breast cancer	8.61e-06	0.000152	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HPGDS—breast cancer	8.45e-06	0.000149	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HBA1—breast cancer	8.39e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NQO1—breast cancer	8.37e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC2A1—breast cancer	8.37e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA3—breast cancer	8.2e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMMR—breast cancer	8.2e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCC1—breast cancer	8.2e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ACHE—breast cancer	8.19e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTT1—breast cancer	8.19e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	8.19e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP3A4—breast cancer	8.16e-06	0.000144	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	8.12e-06	0.000143	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—COMT—breast cancer	8.11e-06	0.000143	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTP1—breast cancer	8.07e-06	0.000143	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1B1—breast cancer	8.02e-06	0.000142	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMOX1—breast cancer	7.96e-06	0.000141	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ITPR1—breast cancer	7.94e-06	0.00014	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.94e-06	0.00014	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HSP90AA1—breast cancer	7.87e-06	0.000139	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP17A1—breast cancer	7.76e-06	0.000137	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ENO1—breast cancer	7.68e-06	0.000136	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS1—breast cancer	7.68e-06	0.000136	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOA1—breast cancer	7.65e-06	0.000135	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.65e-06	0.000135	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCB1—breast cancer	7.64e-06	0.000135	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.55e-06	0.000133	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP19A1—breast cancer	7.54e-06	0.000133	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—STK11—breast cancer	7.54e-06	0.000133	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2D6—breast cancer	7.53e-06	0.000133	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TYMS—breast cancer	7.51e-06	0.000133	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CA9—breast cancer	7.5e-06	0.000132	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA4—breast cancer	7.5e-06	0.000132	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PLA2G4A—breast cancer	7.42e-06	0.000131	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NCOR1—breast cancer	7.42e-06	0.000131	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—breast cancer	7.42e-06	0.000131	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOA2—breast cancer	7.39e-06	0.000131	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA2—breast cancer	7.31e-06	0.000129	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPX2—breast cancer	7.31e-06	0.000129	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SULT1A1—breast cancer	7.22e-06	0.000127	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPX4—breast cancer	7.22e-06	0.000127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—FASN—breast cancer	7.17e-06	0.000127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—BCHE—breast cancer	7.14e-06	0.000126	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GPX1—breast cancer	7.1e-06	0.000125	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.08e-06	0.000125	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC5A5—breast cancer	7.05e-06	0.000125	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—IDH1—breast cancer	7.05e-06	0.000124	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA1—breast cancer	7.05e-06	0.000124	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A1—breast cancer	7.03e-06	0.000124	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—COMT—breast cancer	7.01e-06	0.000124	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTP1—breast cancer	6.98e-06	0.000123	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ERCC2—breast cancer	6.98e-06	0.000123	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NAT2—breast cancer	6.97e-06	0.000123	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMOX1—breast cancer	6.88e-06	0.000122	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ITPR1—breast cancer	6.87e-06	0.000121	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NQO1—breast cancer	6.81e-06	0.00012	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC2A1—breast cancer	6.81e-06	0.00012	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.67e-06	0.000118	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP3A4—breast cancer	6.64e-06	0.000117	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.61e-06	0.000117	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCB1—breast cancer	6.61e-06	0.000117	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTHFR—breast cancer	6.56e-06	0.000116	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1B1—breast cancer	6.53e-06	0.000115	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TYMS—breast cancer	6.49e-06	0.000115	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOR1—breast cancer	6.41e-06	0.000113	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—breast cancer	6.41e-06	0.000113	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLA2G4A—breast cancer	6.41e-06	0.000113	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSP90AA1—breast cancer	6.4e-06	0.000113	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOA1—breast cancer	6.23e-06	0.00011	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GPX1—breast cancer	6.14e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—STK11—breast cancer	6.14e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP19A1—breast cancer	6.14e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MED12—breast cancer	6.11e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—DPYD—breast cancer	6.11e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A1—breast cancer	6.08e-06	0.000107	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CAV1—breast cancer	6.05e-06	0.000107	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ERCC2—breast cancer	6.03e-06	0.000106	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDOA—breast cancer	6.02e-06	0.000106	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOA3—breast cancer	5.84e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC2A2—breast cancer	5.8e-06	0.000102	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.76e-06	0.000102	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—COMT—breast cancer	5.71e-06	0.000101	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCG2—breast cancer	5.68e-06	0.0001	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CPT1A—breast cancer	5.68e-06	0.0001	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTR—breast cancer	5.68e-06	0.0001	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTP1—breast cancer	5.68e-06	0.0001	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTHFR—breast cancer	5.67e-06	0.0001	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMOX1—breast cancer	5.6e-06	9.89e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ITPR1—breast cancer	5.59e-06	9.87e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HPGDS—breast cancer	5.57e-06	9.84e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HBA1—breast cancer	5.54e-06	9.78e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CG—breast cancer	5.51e-06	9.73e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ACHE—breast cancer	5.4e-06	9.54e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTT1—breast cancer	5.4e-06	9.54e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCB1—breast cancer	5.38e-06	9.49e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TYMS—breast cancer	5.28e-06	9.32e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CAV1—breast cancer	5.23e-06	9.23e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOR1—breast cancer	5.22e-06	9.22e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—breast cancer	5.22e-06	9.22e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLA2G4A—breast cancer	5.22e-06	9.22e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP17A1—breast cancer	5.12e-06	9.03e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ENO1—breast cancer	5.06e-06	8.94e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS1—breast cancer	5.06e-06	8.94e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GPX1—breast cancer	5e-06	8.83e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.99e-06	8.82e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2D6—breast cancer	4.97e-06	8.77e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A1—breast cancer	4.95e-06	8.74e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ERCC2—breast cancer	4.91e-06	8.67e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOA2—breast cancer	4.87e-06	8.61e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CD—breast cancer	4.84e-06	8.55e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALB—breast cancer	4.78e-06	8.44e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CG—breast cancer	4.76e-06	8.41e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—FASN—breast cancer	4.73e-06	8.35e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—BCHE—breast cancer	4.71e-06	8.31e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC5A5—breast cancer	4.65e-06	8.21e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTHFR—breast cancer	4.61e-06	8.15e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NOS3—breast cancer	4.57e-06	8.08e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NQO1—breast cancer	4.49e-06	7.93e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC2A1—breast cancer	4.49e-06	7.93e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1B1—breast cancer	4.31e-06	7.6e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CAV1—breast cancer	4.25e-06	7.51e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.22e-06	7.46e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CB—breast cancer	4.22e-06	7.45e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CD—breast cancer	4.19e-06	7.39e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—breast cancer	4.18e-06	7.39e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALB—breast cancer	4.13e-06	7.3e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOA1—breast cancer	4.11e-06	7.25e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.06e-06	7.18e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—STK11—breast cancer	4.05e-06	7.15e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP19A1—breast cancer	4.05e-06	7.15e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NOS3—breast cancer	3.95e-06	6.98e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CG—breast cancer	3.88e-06	6.84e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—COMT—breast cancer	3.76e-06	6.65e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTP1—breast cancer	3.75e-06	6.61e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMOX1—breast cancer	3.69e-06	6.52e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ITPR1—breast cancer	3.69e-06	6.51e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CB—breast cancer	3.65e-06	6.44e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTEN—breast cancer	3.65e-06	6.44e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—breast cancer	3.62e-06	6.38e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCB1—breast cancer	3.55e-06	6.26e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TYMS—breast cancer	3.48e-06	6.15e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOR1—breast cancer	3.44e-06	6.08e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—breast cancer	3.44e-06	6.08e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.44e-06	6.08e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CD—breast cancer	3.41e-06	6.02e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALB—breast cancer	3.36e-06	5.94e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPX1—breast cancer	3.3e-06	5.82e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A1—breast cancer	3.26e-06	5.76e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ERCC2—breast cancer	3.24e-06	5.71e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NOS3—breast cancer	3.22e-06	5.68e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTEN—breast cancer	3.15e-06	5.57e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTHFR—breast cancer	3.04e-06	5.37e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CB—breast cancer	2.97e-06	5.24e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—breast cancer	2.94e-06	5.2e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CAV1—breast cancer	2.81e-06	4.95e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CA—breast cancer	2.57e-06	4.54e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTEN—breast cancer	2.57e-06	4.53e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.56e-06	4.51e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CD—breast cancer	2.25e-06	3.97e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CA—breast cancer	2.22e-06	3.93e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALB—breast cancer	2.22e-06	3.92e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NOS3—breast cancer	2.12e-06	3.75e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKT1—breast cancer	2.1e-06	3.71e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.96e-06	3.46e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—breast cancer	1.94e-06	3.43e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKT1—breast cancer	1.82e-06	3.21e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.81e-06	3.2e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTEN—breast cancer	1.69e-06	2.99e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKT1—breast cancer	1.48e-06	2.61e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.19e-06	2.11e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKT1—breast cancer	9.75e-07	1.72e-05	CbGpPWpGaD
